ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD) today announced that a satellite symposium, podium presentations, and key abstracts related to the Company’s embolic products for the treatment of symptomatic uterine fibroids, liver cancer and arteriovenous malformations have been accepted at the Society for Interventional Radiologists (SIR) 33rd Annual Scientific Meeting being held March 15-20, 2008 in Washington, D.C. BioSphere’s booth number is 1213.
